My to-read list this weekend includes a range of papers along with various news & media including a report of two US research groups aiming to get CRISPR baby patents. More on that below. At long last a trip + fun thing to do in NYC Last week I took my first trip in more …
Weekly reads: escape to New York, CRISPR baby patents, ISSCR guidelines, pubs Read More »
Sometimes it seems like a bunch of stuff in one area, like with CRISPR this week, happens all of a sudden in science. A bunch of fairly high-profile gene editing pubs came out. They generated a lot of news reports. Other news in this arena popped up too, all within a few days. In vivo …
CRISPR update: lots of new pubs, news, & maybe a patent finale Read More »
Some months back a USPTO court issued a ruling that most interpreted as meaning the Broad Institute had won the so-called ‘CRISPR patent battle’ in the U.S. and that UC Berkeley, Jennifer Doudna, and Emmanuelle Charpentier had lost. Now this week Berkeley has appealed that ruling. It seems the odds are against Berkeley prevailing in its appeal, but frankly …
STAP is back? Really? No, I don’t believe so, but there’s an interesting development and twist on the STAP cell front. Just a few days ago on January 4, 2017 Dr. Charles Vacanti, the originator of the STAP cells concept, submitted a declaration to the USPTO affirming the belief that STAP cells are real and requesting that …
STAP cells (stap細胞) are real deal says new Vacanti patent declaration Read More »
It’s been a busy few weeks for the CRISPR arena so I’ve made a CRISPR Update. I’ve listed below links to some commentaries and key developments. Fun Video interview on Read Science! with Joanne Manaster on my new book on CRISPR in humans, GMO Sapiens. CRISPR: Pursuit of profit poisons collaboration, Nature piece by Jacob Sherkow …
There’s a lot going on in the world of stem cells making for many striking headlines lately. Here are some stem cell headlines that caught my attention. Haploid Stem Cells Created. Could these cells be used to make germ cells? Charlatans and snake-oil salesmen ‘hijacking stem cell therapies’ in Australia In the CRISPR patent fight, the Broad Institute gains edge. The CRISPR-Cas9 patent …
Stem cell headlines: half a genome, Australian snake oil, CRISPR patent battle Read More »
Who really invented CRISPR? If it was many people and labs, who did it first and who deserves the credit? When things like Nobel Prizes and Patents get decided on CRISPR-Cas9, who will be for lack of a better way of putting it, the winners and the losers? It’s not a trivial question and despite …
A hunch on that CRISPR patent battle as it heats up Read More »
The patent dispute on CRISPR between UC/Jennifer Doudna and The Broad/Feng Zhang has been the subject of major attention including in a recent piece on Stanford Center for Law & Biosciences Blog. There is a lot of confusion over this important CRISPR dispute so I turned to a patent expert for their take on this via an interview …
Patent expert weighs in on CRISPR dispute between UC & Broad Read More »
A lot has been going on in the CRISPR world. Here are some key CRISPR updates. Editas has filed the paperwork on the road to going public as a company. Such an IPO, should it come to fruition, could raise billions of dollars. Will the other CRISPR companies like Caribou and CRISPR Therapeutics follow suit? Simplistically, …
New #CRISPR updates: Editas to go public, patent issues, dragons & more Read More »
With more than 250 votes cast, Jennifer Doudna is leading by a decisive margin in a poll asking who deserves the patent for use of CRISPR-Cas9 as a tool. Feng Zhang got only just over half the votes of Doudna. Another take home message from this poll is that a sizable minority–almost one in five– said …
Doudna most deserving of CRISPR Cas9 patent, says poll Read More »